Market Challenges And Opportunities

Global Intensity-Modulated Proton Therapy Market- Restraints

Intensity modulated proton therapy devices are large in size and also occupy larger space. The investment is high due to additional setup cost of the equipment which increases the investment cost and thereby limits the market growth. Moreover, high cost proton therapy is expected to affect the growth of the market. For instance, according to The Institute of Clinical and Economic Review, the cost of intensity modulated proton therapy for cancer patients in the U.S is US$ 73,000. These factors are expected to restrain the growth of the global intensity modulated proton therapy market.

Global Intensity-Modulated Proton Therapy Market- Drivers

The rising prevalence of non-communicable diseases such as cancer is a major burden globally. According to the World Health Organization, cancer accounted for around 9.6 million deaths across the globe in 2018. Moreover, healthcare facilities are focusing on adoption of intensity modulated proton therapy due to its safety and efficiency in treatment of cancer. In February 2020, IBA Ion Bean Application announced that they have signed a contract to install Proteus ONE, a compact proton therapy at RSPAD Gatot Soebroto Presidential Hospital in Jakarta, Indonesia.